sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 151-175 out of 1317.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>

Public Release: 12-Sep-2016
PLOS Genetics
A chromosome anomaly may cause malaria-transmitting mosquito to prefer feeding on cattle
Mosquitoes are more likely to feed on cattle than on humans if they carry a specific chromosomal rearrangement in their genome, reducing their odds of transmitting the malaria parasite, reports Bradley Main at the University of California, Davis in a study published Sept. 12, 2016, in PLOS Genetics.

Contact: Bradley Main
bradmain@gmail.com
PLOS

Public Release: 12-Sep-2016
PLOS Genetics
Genetic causes of small head size share common mechanism
Microcephaly is a rare disorder that stunts brain development in utero, resulting in babies with abnormally small heads. The Zika virus is one environmental cause of this devastating condition, but genetic defects can cause microcephaly, too. A new Duke University study examining three genetic causes of microcephaly in mice suggests one common mechanism through which the disorder could arise. The results could enhance understanding of microcephaly and other neurodevelopmental disorders, including autism.
National Institutes of Health, Ruth K. Broad Foundation, Duke Translational Research Institute

Contact: Robin Smith
ras10@duke.edu
919-681-8057
Duke University

Public Release: 9-Sep-2016
SA Heart Congress 2016
Novel heart valve replacement offers hope for thousands with rheumatic heart disease
A novel heart valve replacement method is revealed today that offers hope for the thousands of patients with rheumatic heart disease who need the procedure each year. The research is being presented at the SA Heart Congress 2016.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 8-Sep-2016
Nature
Experts urge a defensive stance in efforts against antimicrobial resistance
In a Comment in Nature, CDDEP Director Ramanan Laxminarayan and other experts in antimicrobial resistance suggest that the United Nations should reframe global efforts against antimicrobial resistance by adopting a defensive stance. The suggested focus should be in building the resilience of society and maintaining diversity in the 'global microbiome'-- only a fraction of which causes human or animal disease.

Contact: Ellyse Stauffer
communications@CDDEP.org
202-328-5152
Burness

Public Release: 7-Sep-2016
Clinical Microbiology Reviews
No consensus on how the microbiome affects tuberculosis, review finds
Inconsistencies across studies and sampling errors remain major barriers to understanding how the lung microbiome changes with tuberculosis, according to a review published today in Clinical Microbiology Reviews.

Contact: Sergio Ramirez
s.ramirez@ttuhsc.edu
915-205-1156
Texas Tech University Health Sciences Center El Paso

Public Release: 6-Sep-2016
Journal of Infectious Diseases
Early study shows RTS,S malaria vaccine efficacy may improve by changing dosing schedule
Researchers at the Walter Reed Army Institute of Research (WRAIR) and collaborators recently published results of a phase II study which demonstrated that by changing the dosing regimen, the efficacy of malaria vaccine candidate, RTS,S/AS01, was improved to approximately 87 percent, compared with 63 percent using the current standard regimen.
GSK, US Military Infectious Disease Research Program, PATH Malaria Vaccine Initiative

Contact: Dr. Debra Yourick
debra.l.yourick.civ@mail.mil
301-319-9471
Walter Reed Army Institute of Research

Public Release: 6-Sep-2016
Journal of Cell Biology
SickKids-led project investigates malnutrition in children, liver impairments
In a new Journal of Cell Biology study, SickKids researchers identify a gene, PEX2, as an essential requirement for the loss of peroxisomes in cells cultured without enough nutrients. The study's findings contribute to a project on novel treatment strategies for severely malnourished children.
Canadian Institutes of Health Research, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, SickKids Foundation

Contact: Hillete Warner
hillete.warner@sickkids.ca
416-550-2779
Rockefeller University Press

Public Release: 6-Sep-2016
Could a 'metabolic fingerprint' identify premature babies in developing countries?
Canadian researchers are hoping that metabolic markers found in blood spots routinely collected from infant heel pricks as part of newborn screening will help determine gestational age in newborns and lead to better care for infants in developing countries.
Bill & Melinda Gates Foundation

Contact: Adrienne Vienneau
avienneau@cheo.on.ca
613-737-7600 x4144
Children's Hospital of Eastern Ontario Research Institute

Public Release: 6-Sep-2016
Journal of Global Health
Healthcare corruption taken to task by technology, study shows
Mobile phone technology could help to beat bad practices in healthcare delivery, research led by the University of Edinburgh suggests.

Contact: Jen Middleton
jen.middleton@ed.ac.uk
44-131-650-6514
University of Edinburgh

Public Release: 6-Sep-2016
European Journal of Preventive Cardiology
European standards to prevent repeat heart attacks launched today
European standards to prevent repeat heart attacks are published today in the European Journal of Preventive Cardiology. The standards were defined by the European Society of Cardiology.
European Association for Cardiovascular Prevention and Rehabilitation, Acute Cardiovascular Care Association

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 2-Sep-2016
PLOS Neglected Tropical Diseases
New model could help improve prediction of outbreaks of Ebola and Lassa fever
Potential outbreaks of diseases such as Ebola and Lassa fever may be more accurately predicted thanks to a new mathematical model developed by researchers at the University of Cambridge. This could in turn help inform public health messages to prevent outbreaks spreading more widely.
Ecosystem Services for Poverty Alleviation

Contact: Stuart James Roberts
sjr81@Admin.cam.ac.uk
01-223-332-300
University of Cambridge

Public Release: 1-Sep-2016
Lancet Infectious Diseases
Countries across Africa, Asia-Pacific vulnerable to Zika virus, new study finds
Parts of Africa and the Asia-Pacific region may be vulnerable to outbreaks of the Zika virus, including some of the world's most populous countries and many with limited resources to identify and respond to the mosquito-borne disease, a new study says.

Contact: Geoff Koehler
koehlerg@smh.ca
416-864-5960
St. Michael's Hospital

Public Release: 1-Sep-2016
Science
Dengue vaccine could increase or worsen dengue in some settings
The only approved vaccine for dengue may actually increase the incidence of dengue infections requiring hospitalization rather than preventing the disease if health officials aren't careful about where they vaccinate, new public health research published Sept. 2 in Science suggests.
UK Medical Research Council, UK National Institute of Health Research, NIH/National Institute of Allergy and Infectious Diseases, NIH/National Institute of General Medical Sciences

Contact: Stephanie Desmon
sdesmon1@jhu.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health

Public Release: 31-Aug-2016
Journal of Clinical Virology
Study suggests size of Zika epidemic may be underestimated
A study at the São José do Rio Preto Medical School (FAMERP) in São Paulo State, Brazil, suggests official statistics may underestimate the size of the epidemic caused by Zika virus. Some cases of Zika may be misreported as dengue. Uncertainty about the statistics tends to undermine the effectiveness of public policy to prevent and treat diseases, the authors also argue.
São Paulo Research Foundation

Contact: Samuel Antenor
samuel@fapesp.br
55-113-838-4381
Fundação de Amparo à Pesquisa do Estado de São Paulo

Public Release: 30-Aug-2016
ESC Congress 2016
Caution urged in the use of blood pressure lowering treatment for heart disease patients
Caution has been urged in the use of blood pressure lowering treatment for heart disease patients after a study in more than 22 000 patients with coronary artery disease found that too low blood pressure was associated with worse outcomes. The analysis from the CLARIFY registry is presented today at ESC Congress and published in The Lancet.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
Family Medicine and Community Health
Global reach of Family Medicine and Community Health
The global reach of family medicine and community health is the theme of the new issue of Family Medicine and Community Health, an international medical journal with editorial offices in China and the US.
Chinese General Practice Press

Contact: Virginia O'Brien
vobrien@compuscript.com
353-614-72743
Family Medicine and Community Health

Public Release: 30-Aug-2016
ESC Congress 2016
A rapid and effective antidote for anticoagulant bleeds
A specially designed antidote to reverse acute, potentially life-threatening anticoagulant-related bleeding worked quickly, and was well-tolerated according to interim results of the ongoing ANNEXA-4 study.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
ESC Congress 2016
ENSURE-AF trial edoxoban: A new anticoagulant option before cardioversion
Patients with atrial fibrillation who need anticoagulation before undergoing electrical correction of their abnormal heartbeat (cardioversion) may benefit from treatment with edoxoban -- a non-vitamin K antagonist oral anticoagulant, according to results of the ENSURE-AF trial.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
ESC Congress 2016
REVERSE II trial decision rule helps identify women who can safely discontinue anticoagulants
A clinical decision rule that can be applied to women after a first, unprovoked venous thromboembolism was able to identify those with a low-risk of recurrence who could safely discontinue anticoagulant therapy, researchers reported at ESC Congress 2016.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
ESC Congress 2016
YEARS algorithm in suspected pulmonary embolism: Towards a reduced rate of pulmonary imaging
Patients with suspected pulmonary embolism often undergo computed tomography pulmonary angiography to confirm or exclude the diagnosis.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
ESC Congress 2016
European Heart Journal
Intravascular imaging identifies some heart attack patients who can forgo stenting
More than one-quarter of heart attack patients who are normally treated with stents to reopen their blocked arteries might be able to forgo this procedure and receive anti-thrombotic medications only, according to results of a pilot study.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
ESC Congress 2016
European Heart Journal
First randomized trial compares stenting techniques for coronary bifurcation
Coronary bifurcations -- a type of coronary artery narrowing -- are best treated with a technique known as culotte stenting, as opposed to T-and-protrusion stenting, when there is need for a side-branch stent according to results of the BBK II (Bifurcations Bad Krozingen) trial.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
ESC Congress 2016
BASKET-SAVAGE trial: Drug-eluting stents more benefit in saphenous vein grafts
Drug-eluting stents had a clear advantage over bare metal stents in patients undergoing revascularization of saphenous (leg) vein grafts, results of the BASKET-SAVAGE trial show.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
ESC Congress 2016
Less efficacy than expected in largest drug-eluting stent trial
New generation drug-eluting stents did not outshine contemporary bare metal stents as they were expected to, in a surprise finding of the largest randomized stent trial to date.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 30-Aug-2016
ESC Congress 2016
PRAGUE-18 trial: Prasugrel and ticagrelor: Equally safe and effective in STEMI
The antiplatelet drugs prasugrel and ticagrelor had similar safety and efficacy among patients with acute myocardial infarction and ST segment elevations (STEMI), according to results of PRAGUE-18, the first randomized, head-to-head comparison of the drugs.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Showing releases 151-175 out of 1317.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>